New Benzimidazole-Triazole Derivatives as Topoisomerase I Inhibitors: Design, Synthesis, Anticancer Screening, and Molecular Modeling Studies

Topoisomerase, ADME, In silico, Chemistry, Benzimidazole, Cytotoxicity, IC50, Stereochemistry, Docking (animal), A549 cell, Molecular model, Doxorubicin, Triazole, Enzyme, Combinatorial chemistry, Biochemistry, In vitro, Biology, Organic chemistry